Inventor

DO HUNG V

US19 patents

⚠️ This page may combine multiple inventors who share the name “DO HUNG V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DO HUNG V

AMICUS THERAPEUTICS INC

Method to predict response to pharmacological chaperone treatment of diseases

Method to predict response to pharmacological chaperone treatment of diseases

Method to predict response to pharmacological chaperone treatment of diseases

Highly potent acid alpha-glucosidase with enhanced carbohydrates

Highly potent acid alpha-glucosidase with enhanced carbohydrates

Augmented acid alpha-glucosidase for the treatment of Pompe disease

Augmented acid alpha-glucosidase for the treatment of Pompe disease

Method for selection of high M6P recombinant proteins

Highly potent acid alpha-glucosidase with enhanced carbohydrates

Highly potent acid alpha-glucosidase with enhanced carbohydrates

Augmented acid alpha-glucosidase for the treatment of Pompe disease

Method for selection of high M6P recombinant proteins

Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity

Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity

Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity

BENJAMIN ELFRIDA

Method to predict response to pharmacological chaperone treatment of diseases

AMICUS THERAPEUTICS

Method to predict response to pharmacological chaperone treatment of diseases

DO HUNG V

Utilization of pharmacological chaperones to improve manufacturing and purification of biologics

UNIV EMORY

Compositions and methods for the expression of factor VIII polypeptides and uses therefor